Literature DB >> 2056143

High-dose intravenous haloperidol for agitated delirium in a cardiac patient on intra-aortic balloon pump.

K M Sanders, G B Murray, N H Cassem.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056143     DOI: 10.1097/00004714-199104000-00021

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  8 in total

1.  Dexmedetomidine, agitated delirium, and "off-label" drugs.

Authors:  Genís Carrasco; Nacho Baeza; Lluís Cabré
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 2.  Haloperidol dosing strategies in the treatment of delirium in the critically ill.

Authors:  Erica H Z Wang; Vincent H Mabasa; Gabriel W Loh; Mary H H Ensom
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

3.  A retrospective study of the psychiatric management and outcome of delirium in the cancer patient.

Authors:  S M Olofsson; M A Weitzner; A D Valentine; W F Baile; C A Meyers
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

Review 4.  Delirium and sedation in the ICU.

Authors:  Jennifer A Frontera
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

Review 5.  Psychiatric complications in the critically ill cardiac patient.

Authors:  K M Sanders; E H Cassem
Journal:  Tex Heart Inst J       Date:  1993

Review 6.  Antipsychotics in older patients. A safety perspective.

Authors:  B G Pollock; B H Mulsant
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

7.  Delirium and Agitation.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-03       Impact factor: 3.972

Review 8.  Adaptation of the Pharmacological Management of Delirium in ICU Patients in Iran: Introduction and Definition.

Authors:  Mohammad Arbabi; Fatemeh Shahhatami; Mojtaba Mojtahedzadeh; Mostafa Mohammadi; Padideh Ghaeli
Journal:  Iran J Psychiatry       Date:  2018-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.